Gilead Sciences said on Saturday that it entered into a partnership with Denmark’s LEO Pharma to develop programs to treat patients with inflammatory diseases.
Trending
- UK deploys warship in the Mediterranean to protect British bases in Cyprus
- Film show: 'The Bride!' puts Frankenstein in the shade
- Germany, others partially release oil reserves amid Iran war
- How AI can identify breast cancer ‘better’ than a doctor but there’s a catch | Science, Climate & Tech News
- 'Icky and heartbreaking': The $2 per hour worker behind the OnlyFans boom
- Is lekker lang uitslapen nou gezond, of juist niet?
- Maternity inquiry chair named in government U-turn
- British theatre is beating Broadway – but still has one massive problem | Ents & Arts News
Gilead, LEO Pharma partner to develop programs for inflammatory diseases
By Reuters Econ
